Management of endocrine disease: diagnosis and management of the patient with non-classic CAH due to 21-hydroxylase deficiency

A Nordenström, H Falhammar - European journal of …, 2019 - academic.oup.com
Non-classic congenital adrenal hyperplasia (NCAH) is a relatively common disorder
regardless of ethnicity, but most cases are never diagnosed, especially in males. A baseline …

Testicular adrenal rest tumors: current insights on prevalence, characteristics, origin, and treatment

M Engels, PN Span, AE van Herwaarden… - Endocrine …, 2019 - academic.oup.com
This review provides the reader with current insights on testicular adrenal rest tumors
(TARTs), a complication in male patients with congenital adrenal hyperplasia (CAH). In …

Long‐term health consequences of congenital adrenal hyperplasia

R Pofi, X Ji, NP Krone, JW Tomlinson - Clinical Endocrinology, 2024 - Wiley Online Library
Congenital adrenal hyperplasia (CAH) caused by 21‐hydroxylase deficiency accounts for
95% of all CAH cases and is one of the most common inborn metabolic conditions. The …

Nonclassic congenital adrenal hyperplasia due to 21-hydroxylase deficiency: clinical presentation, diagnosis, treatment, and outcome

H Falhammar, A Nordenström - Endocrine, 2015 - Springer
Nonclassic congenital adrenal hyperplasia (NCAH) is one of the most frequent autosomal
recessive disorders in man with a prevalence ranging from 0.1% in Caucasians up to a few …

Clinical perspectives in congenital adrenal hyperplasia due to 3β-hydroxysteroid dehydrogenase type 2 deficiency

AM Al Alawi, A Nordenström, H Falhammar - Endocrine, 2019 - Springer
Purpose 3β-hydroxysteroid dehydrogenase type 2 deficiency (3βHSD2D) is a very rare
variant of congenital adrenal hyperplasia (CAH) causing less than 0.5% of all CAH. The aim …

Poor compliance and increased mortality, depression and healthcare costs in patients with congenital adrenal hyperplasia

S Jenkins-Jones, L Parviainen, J Porter… - European journal of …, 2018 - academic.oup.com
Objectives To evaluate the risks of depression and all-cause mortality, healthcare utilisation
costs and treatment adherence in congenital adrenal hyperplasia (CAH) in the United …

Adrenal diseases during pregnancy: pathophysiology, diagnosis and management strategies

M Kamoun, MF Mnif, N Charfi, FH Kacem… - The American journal of …, 2014 - Elsevier
Adrenal diseases—including disorders such as Cushing's syndrome, Addison's disease,
pheochromocytoma, primary hyperaldosteronism and congenital adrenal hyperplasia—are …

Health related quality of life of children and adolescents with congenital adrenal hyperplasia in Brazil

DLS Gilban, PAG Alves Junior, ICR Beserra - Health and Quality of Life …, 2014 - Springer
Abstract Background Congenital Adrenal Hyperplasia (CAH) is an endocrine disorder
characterized by enzymatic deficiency in adrenal steroidogenesis, leading to adrenal …

Cardiometabolic Aspects of Congenital Adrenal Hyperplasia

R Krysiak, HL Claahsen-van der Grinten… - Endocrine …, 2025 - academic.oup.com
Abstract Treatment of classic congenital adrenal hyperplasia (CAH) is directed at replacing
deficient hormones and reducing androgen excess. However, even in the era of early …

[HTML][HTML] Prevalence and ultrasound patterns of testicular adrenal rest tumors in adults with congenital adrenal hyperplasia

B Corcioni, M Renzulli, G Marasco… - Translational …, 2021 - ncbi.nlm.nih.gov
Background Testicular adrenal rest tumors (TARTs) are benign neoplasms affecting patients
with congenital adrenal hyperplasia (CAH). The prevalence of TART in adult patients with …